首页> 外文会议>Proceedings of the 31st annual conference of the North American Thermal Analysis Society(NATAS) >Thermal Behaviour the Ampicillin Drug Substance in Plasma Using DSC-Cooling
【24h】

Thermal Behaviour the Ampicillin Drug Substance in Plasma Using DSC-Cooling

机译:使用DSC冷却的氨苄青霉素药物在血浆中的热行为

获取原文
获取原文并翻译 | 示例

摘要

The present study proposes the using of DSC-Cooling with Peltier refrigeration systemrnas tool of ampicillin thermal behavior in human plasma. The ampicillin was submittedrnto a complete thermal studies, that includes: calorimetric profiles, 3 cycles of freezethawingrnisothermal and isothermal behavior. The parameters obtained wererntemperatures onset and transition phase energies of crystallization and melting to verifyrnthe water stability in pure water and water in plasma containing ampicillin. The equationrnof Avrami was used for determination the formation rate and growth mechanism of thernnuclei to kinetic evaluation. DSC-Cooling data of the pure water presented temperaturernonset of 252 K and 272 K, respectively, for the crystallization and melting processes.rnThe plasma presents 99% of water and 1% of macro and micromolecules, such asrnproteins and fats, it showed an anticipation of the temperatures onset of crystallizationrnand melting for 256 K and 271 K, respectively. This can be explained by the capacityrnthat these molecules have to keep energy in comparison with pure water that crystallizesrnin larger temperatures. These data are confirmed by the rate constant and index ofrnAvrami, that are larger for the water (k= 1.08 ± 0.09, n= 1.78 ± 0.12) than for thernplasma (k= 0.67 ± 0.02, n= 1.28 ± 0.06). The ampicillin drug substance did not changernthe thermal parameters in water, but it showed an increase of the temperature onset ofrncrystallization and melting in the human plasma. DSC-Cooling data demonstrated greatrnpotentiality for the freeze-thawing studies of drugs in plasma.
机译:本研究提出了在人血浆中使用氨苄青霉素热行为的Peltier制冷systemrnas工具进行DSC冷却。氨苄青霉素已提交完整的热学研究,其中包括:量热曲线,3个冻融等温和等温行为循环。所获得的参数为结晶和熔融的温度开始和过渡相能,以验证纯净水和含氨苄青霉素血浆中水的稳定性。用方程式Avrami来确定核的形成速率和生长机理以进行动力学评估。纯水的DSC冷却数据显示,结晶和熔融过程的温度分别为252 K和272 K.rn血浆中存在99%的水,以及1%的大分子和小分子(如蛋白质和脂肪),表明了预期结晶温度和熔化温度分别为256 K和271K。这可以用与在较大温度下结晶的纯水相比,这些分子必须保持能量的能力来解释。这些数据可以通过速率常数和rnAvrami指数得到确认,其中水的比率(k = 1.08±0.09,n = 1.78±0.12)要比血浆的比率(k = 0.67±0.02,n = 1.28±0.06)大。氨苄西林原料药并没有改变水中的热参数,但显示出人类血浆中结晶和融化的温度升高。 DSC冷却数据证明了血浆中药物冻融研究的巨大潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号